drugset / Trial / NCT06194318
First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults
RandomizedParallel-groupQuadruple-blindPrevention
Summary
First-in-human Safety and Immunogenicity Study of SCB-1019 and SCB-1019T in Healthy Adults
Timeline
- Start
- 2023-12-13
- Primary completion
- 2025-02-26
- Completion
- 2025-05-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Arexvy | Vaccine | — | — |
| Subject | SCB-1019 | Vaccine | — | — |
| Subject | SCB-1019T | Vaccine | — | — |